Judge Keeps Sales Ban In Cephalon Generic Amrix Patent Row

Law360, New York (September 19, 2012, 4:51 PM EDT) -- A Delaware federal judge on Tuesday extended an injunction barring Impax Laboratories Inc. from selling a generic version of Cephalon Inc.'s muscle relaxant Amrix, after an appeals court ruling set a Sept. 15 expiration date on a standing injunction.

U.S. District Judge Sue L. Robinson signed off on Cephalon's proposed order, which keeps in place an injunction first issued in May 2011 that blocks Impax from selling generic Amrix. Impax had previously attempted to amend the injunction after reaching a settlement with Cephalon in the underlying...
To view the full article, register now.